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Abstract
Background: The expression of miR-302 over the period of early embryogenesis could
possibly regulate the maternal transcript clearance. Zygotic transcription activation is
mostly related to maternal messages degradation.
Objective: In this study, the effects of in-vitro maturation technique (IVM) on the
expression of miR-302 in human embryo produced from immature and mature human
oocytes (matured in vitro and in vivo, before sperm exposure) obtained from females
under gonadotrophin therapy were evaluated for assisted reproduction.
Materials and Methods: Immature oocytes were cultured in vitro. The injection of
oocytes-producing polar bodies was given using fresh sperm. Then, the embryo quality
score was assessed in the IVM group compared with the control group. In both the
groups, embryos with normal morphology were included in the molecular study. Only
one blastomere was removed from three-day embryos and then the embryos were
frozen. The expression of miR-302 in embryos was measured through quantitative real-
time polymerase chain reaction.
Results: Our data showed a significant reduction of miR-302 expression in the IVM
group vs. the control group (p = 0.02). The embryo quality score showed a significant
difference between the two groups (p = 0.01).
Conclusion: The present study demonstrated that the IVM process had a negative
effect on the expression level of miR-302 in human pre-implantation embryos.
Considering the major role of expression miR-302, a reduced potential in miR-302
expression could be related to a decrease in the early embryonic development.
Keywords:miR-302, Embryonic development, Ovarian stimulation, In-vitromaturation,
Intracytoplasmic sperm injection.
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1. Introduction
The complete maturation of oocytes is very
substantial in supply and accumulation of maternal
transcription factors (TFs) particularly at the final
step of the oocyte growth phase (the process
in which germinal vesicle (GV) progresses to the
metaphase II stage) (1). The recovery of imma-
ture oocytes, and subsequent in-vitro maturation
(IVM), of such oocytes could be established as
a procedure to cure women with infertility or to
obtain more oocytes or more chances for infertile
couples. No aspect of this therapy technique was
known so far (2). There are many uncertainties
over IVM culture, complete and comprehensive of
oocyte maturation; such as nuclear, membrane,
and cytoplasmic maturation. For the time of early
stages of embryogenesis, development is primarily
controlled by maternal parameters contributed by
the egg cytoplasm, but the zygotic nuclear genome
is inactive. Consequently, the activation of this
genome occurs, products of the embryonic gene
are moved, and the clearance of maternal param-
eters occurs. This developmental control transfer
is known as maternal-to-zygotic transition (MZT)
and is coupled with arising embryonic genome
activation (3).
During MZT and over cellular reprogramming,
the history of the cell is deleted to make possi-
ble the formation of new cellular states via par-
ticular transcription parameters (zygotic state or
pluripotency). Despite the variety of mechanisms
recognized among diverse species to regulate the
expression of a gene, uniting themes, such as the
roles of central TFs and microRNAs (miRNAs) to
direct the MZT emerge, miRNAs were indicated to
control temporal gene expression by downregulat-
ing mRNAs transcribed over earlier developmental
steps (4-7). However, it is important to note that
such miRNAs might play significant roles in the
maternal transcript clearance in mammals. There
are numerous lines of evidence suggesting that
such miRNAs not only contribute to pluripotency
but also have key roles in cellular reprogram-
ming. Importantly, miR-430 (one of the earliest and
most highly transcribed genes originated from the
zygotic genome (8-11)) and miR-427 have abundant
expression during MZT in zebrafish (12, 13) and
Xenopus (14, 15), respectively. miR-302 and miR-
372 are its orthologous in humans (16-19).
According to the previous studies, maternally
prepared parameters have the ability to activate
zygotic gene transcription through the function
of TFs involving the early embryonic genome. In
addition, zygotic genes, such as miRNAs, play an
important role in maternal RNA clearance. The
failure in the activation of the zygotic genome
through the inhibition of maternal TF activity leads
to stabilized maternal program and arrested devel-
opment. miR-302 and miR-372 expression occurs
over early development stages in humans and
primates (20).
Based on the aforementioned information, the
present studywas designed to assess the effects of
oocyte culture onmiR-302 expression in the human
embryo. The aim of this study was to present the
first expression library of miRNAs within the human
embryos derived from the IVM technique to provide
a necessary starting point for future investigations
to improve the IVM.
2. Materials and Methods
2.1. Patients
In the present research, two different experi-
ments were studied. The control group included
16 couples who underwent intracytoplasmic sperm
injection (ICSI) cycles and then pre-implantation
genetic diagnosis (PGD) was done for them. In the
control group, after embryo transfer, the excess
of normal biopsied embryos that were donated
for scientific research. The IVM group included
36 couples who underwent Repeated Implantation
Failure (RIF) treatment and immature oocytes used
at the GV stage in the present study. The exclusion
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criteria were any infertility with female factor as
well as male factor. The age of the female and
male patients were less than 35 and 45 yr old,
respectively.
2.2. Controlled ovarian stimulation
For controlled ovarian stimulation, all the
patients received the standard long protocol of
pituitary suppressionwith gonadotrophin-releasing
hormone agonist. Hypophyseal suppression
of patients was started by administering 0.1
mg of Diphereline (triptorelin; Ipsen Pharma,
Paris, France) or Decapeptyl (triptorelin; Ferring
Pharmaceutical, Germany) in the mid luteal phase
of the previous cycle. Subsequently, we decreased
gonadotropin-releasing hormone analog dose to
0.05 mg until the administration day of human
chorionic gonadotropin (HCG). The patient’s
ovaries were stimulated with recombinant follicle-
stimulating hormone (FSH) (Gonal-F; Merck Serono,
Germany). The initial doses were determined and
administrated based on the patient’s age as well as
basal serum FSH and estradiol levels. The patients
received transvaginal ultrasound. HCG (10000 IU,
IBSA, Lugano) was administrated. After 36-38 hr of
the HCG injection, follicles larger than 11 mm were
punctured, using transvaginal ultrasonography.
2.3. Oocyte insemination and evalua-
tion of embryo quality score
GV oocytes were collected. The oocytes were
denuded with 1% hyaluronidase enzyme (Life
Global, Guilford, CT, USA), gently aspirated using
a hand-drawn glass pipette, and incubated under
mineral oil (Irvine Scientific, USA) for a maximum
of 1-hr in 6% CO2 at 37°C (Memmert, Germany). GV
oocytes were observed using an inverted micro-
scope (SM2800, Nikon) at ×200 magnification.
Our criteria for choosing GV oocytes were based
on the presence of a prominent nucleus in the
homogeneous cytoplasm with any defect in the
overall appearance of oocytes. The GV oocytes
were maintained in a drop containing 20-30 µL of
commercial IVM media (Sage Media, USA, Oocyte
Maturation Medium) supplemented with 75 IU/ml
FSH and 75 IU/ml Luteinizing hormone for 24-30
hr based on the manufacturer’s protocols.
Oocytes showing liberated polar bodies were
injected by sperm, based on the World Health
Organization criteria (21, 22). The injected oocytes
were evaluated following 16-18 hr for the appear-
ance of pronuclei according to our routine screen-
ing procedure. Zygotes were maintained in the
culture media for further 24-30 hr. Three days
after ICSI, the embryos were evaluated and scored
for their cleavage and quality. The morphological
features of embryos were determined according to
a previously published study (23).
2.4. Blastomere biopsy
Three days after ICSI, the embryos moved into
microdrops of biopsy media (LG PGD BIOPSY
medium, Life Global) that were under mineral oil.
Zona pellucida drilling was performed mechani-
cally and one blastomere was biopsied for PGD
analysis. The embryo was transferred into a drop
for embryo vitrification. The embryo was main-
tained into an equilibration solution (Kitazato Bio-
Pharma Co., Ltd., Japan) for 15 min at room tem-
perature (20-27°C), after an initial shrinkage and
recovery. Subsequently, the embryo was aspirated
and placed in the vitrification solution (Kitazato
BioPharma Co., Ltd., Japan) at room temperature
for a period of 1 min and then placed on a cryotop
with aminimum volume of VS solution (24). Cryotop
quickly plunged them into liquid nitrogen.
2.5. RNA isolation and cDNA synthesis
The samples were applied to isolate RNA and
synthesize cDNA, followed by quantitative real-
time (qRT)-polymerase chain reaction (PCR) anal-
ysis. Extraction of RNA, synthesis complementary
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of DNA (cDNA) and analysis were done using the
protocol explained in the previous studies. (25-27).
In brief, the samples were pipetted into Eppendorf
tubes consisting of 1.5 µL lysis buffers. cDNA was
synthesized by the addition of 2 µL poly N, 2 µLmir-
302 primer, and 5 µL nuclease-free water to each
of 2 µL embryo samples. The samples were then
placed in a Bio-Rad thermocycler for 5 min at 75°C
until the reaction was complete. Subsequently, the
tubes were placed on ice, and 5× RT buffer (5
µL), 200 u RT enzyme (1 µL), 10mM dNTP (3 µL),
and 10 u RNase inhibitor (0.25 µL) were added to
the reaction for the reverse transcription (RT). RT
reaction was performed at 25°C for 10 min, 37°C
for 15 min, 42°C for 45 min, and 72°C for 10 min.
Afterward, the samples were kept at 4°C overnight.
Table I indicates the primer sequences used in
this study for qRT-PCR to study the frequency of
the level of mir-302 via Rotor-Gene Q instrument
(Qiagen, Turnberry Lane, Valencia, CA, USA). We
performed RT-PCR reactions and reaction condi-
tions (denaturation, amplification and extension)
based on the protocol described in the previ-
ous study (27). A single gene-specific peak of
different amplification reactions was verified by
melting curve analysis. One reference gene, Snord,
was used for the normalization of the RT-PCR as
an endogenous internal gene. Additionally, we
performed three replications and normalized fold-
change in the mRNA level for each sample to
that of endogenous internal mRNA levels (25,
27).
Table I. Primers used in this study for quantitative real-time PCR
Gene name Primer sequence (50-30 orientation)
miR-302a Forward: GTC GTA TGC AGA GCA GGG TCC GAG GTA TTC GCA CTG CAT ACG ACT CAC
Reverse: CCG CTA AGT GCT TCC ATG TTT TG
SNORD Forward: ATC ACT GTA AAA CCG TTC CA
Reverse: GTC GTA TGC AGA GCA GGG TCC GAG GTA TTC GCA CTG CAT ACG ACA ACC TC
2.6. Ethical consideration
This study was approved by the Ethics Commit-
tee of the Shahid Beheshti University of Medical
Sciences, Tehran, Iran (SBMU.REC.1393.78). In cur-
rent research, written and verbal informed consent
was achieved from the couples who had under-
gone ICSI/PGD according to standard protocols.
2.7. Statistical analysis
All statistical analyses were carried out using
the Statistical Package for the Social Sciences
software, version 22 (SPSS, Chicago, IL, USA). The
embryo quality score was compared using the non-
parametric analysis test (Mann–Whitney U test).
The results are expressed as means % ± SEM. The
relative gene expression level of the related gene
among embryos from two groups was analyzed
by REST 2009 software (Qiagen). p < 0.05 were
considered to be statistically significant.
3. Results
Germinal vesicle oocytes were collected from
36 couples undergoing treatment. The frequency
of harvested GV oocytes ranged from 3 to 6. We
used the results of 16 couples undergoing ICSI-
PGD cycles (Table II). After the development of the
embryos at the 8-cell stage, the embryos having
normal morphological features were chosen for
molecular studies. Embryo quality score reduced
significantly in the IVM group when compared with
the control (p = 0.01) (Table II).
Real-time PCR was performed to assess the
quantitative expression of the studied gene. The
miR-302 levels were measured by qRT-PCR in
8-cell stage embryos derived from ICSI using
Page 408 https://doi.org/10.18502/ijrm.v17i6.4812
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freshly prepared sperm. According to the criteria
explained by theWorld Health Organization, sperm
parameters (such as concentration, motility and
morphology) were determined (21). The morpho-
logical features of sperms were also determined
using the Kruger strict criteria (22). The comparison
of the relative transcript abundancemiR-302mRNA
in embryos derived from ICSI indicated a significant
difference at the levels of this micoRNA, during
human early developmental stages, between the
IVM group and the control group (p = 0.02). Figure
1 indicates the relative levels.
Table II. Demographic characteristics of all evaluated ICSI cycles
Characteristic Group
IVM oocytes Control oocytes
Number of cycles 36 16
Female age (yr) (Mean ± SEM) 30.1 ± 1.2 28.9 ± 1.6
No. of injected oocytes 124 121
Embryo quality score (Mean ± SEM) 1.86 ± 0.67 2.30 ± 0.31
Note: ICSI: Intracytoplasmic Sperm Injection IVM: In-vitro Maturation
Figure 1. miRNA transcript relative quantification. Relative
expression of mRNA of miR-302a in 8-cell stage of human
embryos in the IVM group and control group demonstrated
a statistically significant difference between the two groups.
The mRNA level of each gene was analyzed using quantitative
real time-PCR. In addition, the mRNA levels of each sample
were normalized to the level of Snord mRNA. The data are
presented as mean ± SEM. (*) p < 0.05. The relative gene
expression level of the related gene among embryos from two
groups was analyzed by REST 2009 software (Qiagen).
4. Discussion
The purpose of the present study was to inves-
tigate the effects of the IVM technique on the
expression of miR-302 in human embryos grades
A and B, produced from immature and mature
oocytes (matured in vivo and in vitro, before
sperm exposure) and obtained from females under
gonadotrophin therapy for assisted reproduction.
Themain aspect of the present study was to assess
one of the major miRNAs over early human embry-
onic development in the Assisted Reproductive
Technique (ART). Our findings demonstrated that
miR-302 expression diminished significantly in the
IVM group when compared with the control group
(p = 0.02).
Previously published studies in this field demon-
strated the high expression of miR-302 in the
development of an early human embryo. The
results obtained from those studies, indicating
increased expression over the early period of the
embryo, document a putative role for such miRNAs
already identified in embryonic stem cells (ESC),
demonstrating their major roles in maintaining
pluripotency (20). miRNAs, small non-coding RNA
molecules, regulate genes in numerous biological
systems, including the oocyte and embryo (28).
Previous studies indicated that the stem-cell fac-
tors, such as Oct4, link miR-302 as a promoter
and stimulate its expression in ESCs (6). Epigenetic
reprogramming events have the ability to stimulate
the expression of ESC specific genes, particularly
https://doi.org/10.18502/ijrm.v17i6.4812 Page 409
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Oct4, Sox2, and Nanog, in turn further induce
the expression of miR-302 for the production of
a positive feedback loop cycle having a key role
in maintaining somatic cell reprogramming (SCR)
(29). It has been reported that several possible miR-
302 targets regulate the cell cycle. Therefore, the
regulation of cell-cycle development mediated by
miR-302 may be ascribable to directing multiple
mRNAs. This suggested that miR-302a might be
coordinately directing regulators of multiple G1
phases toward cyclin D1 and Cdk4 for serving
as a negative regulator of G1 (6). Particularly,
this emphasize the main role of miR-302a in
the proliferation of EC cells. Interestingly, miR-
294 in mice and miR-302/372 in humans are
plentifully stated in ESCs and embryonic tissues
(20, 30, 31). Collectively, miR-302 functions in a
single-cell range, such as contributing to erase
the history of cells to make easy the formation
of new cellular states by specific TFs (zygotic
state) and pluripotency, have important roles in
cell reprogramming and cell cycle regulators (6, 17,
29).
Reviewing how mammalian oocytes evolve, we
can find that they obtain a sequence of abilities
over follicular progress (growth of oocyte and mat-
uration of cytoplasm) having important effects on
fertilization and following early embryonic progress
(2, 28). The final preparation of oocytes for fer-
tilization is carried out during oocyte maturation
(from the GV to metaphase II stage) (2). These
factors are applied to maintain the early phase
of embryonic progresses before the beginning of
embryo DNA transcription (32, 33). During the cyto-
plasmic maturation synthesis, essential maternal
materials including maternal TFs are synthesized
that involve the early embryonic genome and
contain miR-302 in human early embryonic devel-
opment. miR-302 is one of the human embryonic
genes whose expression is govern by a wide
variety of factors, containing various functions in
embryonic and stem cells (2). Therefore, based
on our findings, a decrease in the expression
of miR-302 (considering its main role) in the
embryo derived from in-vitro matured oocyte can
be related to a decrease in early embryonic
development so that this reduction cannot be
overlooked.
Generally, the routine assessment of oocyte
morphology using the phase-contrast microscopy
is a key predictive marker used for oocyte quality,
therefore mature oocytes, with full nuclear matu-
ration followed by the first polar body extrusion,
are currently utilized to measure the success or
failure of a given ART program (34). Initial studies
emphasize to “nuclear maturation could occur
suddenly subsequent to the culture in vitro of
animal and human immature oocytes” (2). Nev-
ertheless, the developmental competence after
fertilization in the later stages of these oocytes
is doubtful. Culture conditions considerably affect
the maturation of in-vitro oocytes. Not only normal
morphology and nuclear maturation of oocyte but
also many factors are involved and active in the
early progress of the embryo development, which
is neglected in the IVM method. Therefore, due
to the lack of the probable clinical methods, cyto-
plasmic maturation is ignored in ART programs,
and the embryo development sequences in the
next phases remain unknown andmore studies are
required in this area.
5. Conclusion
The present study indicated that IVM process
had a negative effect at the expression level of miR-
302 in human pre-implantation embryos (despite
the normal morphology for these embryos). There-
fore, these results could change several events
involved in establishing pluripotency and in improv-
ing the activation of zygotic transcription in the
development of the embryo, requiring further
and advanced studies at the molecular level and
improvement of culture media for in-vitro matura-
tion.
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